Complement split products C3a and C4a in chronic Lyme disease

Scandinavian Journal of Immunology

Volumn 69, Issue 1, 2009, Pages 64-69

  Stricker, R B ^a,b   Savely, V R ^a,b   Motanya, N C ^a   Giclas, P C ^c  

^a Union Square Medical Associates ^*  (United States)

^b International Lyme and Associated Diseases Society   (United States)

^c NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIRETROVIRUS AGENT; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C4A;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; LYME DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; BIOLOGICAL MARKERS; CHILD; CHRONIC DISEASE; COMPLEMENT C3A; COMPLEMENT C4A; FEMALE; HUMANS; LYME DISEASE; MALE; MIDDLE AGED; RADIOIMMUNOASSAY; YOUNG ADULT;

EID: 58149092299     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2008.02191.x     Document Type: Article

References (30)

1. Johnson L, Stricker RB. Treatment of Lyme disease: a medicolegal assessment. Expert Rev Anti-Infect Ther 2004 2 : 533 57.
2. Stricker RB. Counterpoint: long-term antibiotic therapy improves persistent symptoms associated with Lyme disease. Clin Infect Dis 2007 45 : 149 57.
3. Stricker RB, Johnson L. Lyme wars: let's tackle the testing. BMJ 2007 335 : 1008.
4. Stricker RB, Winger EE. Decreased CD57 lymphocyte subset in patients with chronic Lyme disease. Immunol Lett 2001 76 : 43 8.
5. Stricker RB, Burrascano J, Winger EE. Longterm decrease in the CD57 lymphocyte subset in a patient with chronic Lyme disease. Ann Agric Environ Med 2002 9 : 111 3.
6. Shoemaker RC, Giclas PC, Crowder C, House D, Glovsky MM. Complement split products C3a and C4a are early markers of acute Lyme disease in tick bite patients in the United States. Int Arch Allergy Immunol 2008 146 : 255 61.
7. Stricker RB, Thomas SL, Moore DH, Winger EE. Efficacy of clarithromycin/cefdinir combination therapy in patients with chronic Lyme disease. J Invest Med 2005 53 : S156.
8. Ahmed AE, Peter JB. Clinical utility of complement assessment. Clin Diagn Lab Immunol 1995 2 : 509 17.
9. Sunyer JO, Boshra H, Li J. Evolution of anaphylatoxins, their diversity and novel roles in innate immunity: insights from the study of fish complement. Vet Immunol Immunopathol 2005 108 : 77 89.
10. Van Beek J, Elward K, Gasque P. Activation of complement in the central nervous system: roles in neurodegeneration and neuroprotection. Ann N Y Acad Sci 2003 992 : 56 71.
11. Haas PJ, van Strijp J. Anaphylatoxins: their role in bacterial infection and inflammation. Immunol Res 2007 37 : 161 75.
12. Bergamaschini L, Gardinali M, Poli M, Lorini R, Bosi E, Agostoni A. Complement activation in diabetes mellitus. J Clin Lab Immunol 1991 35 : 121 7.
13. Richani K, Soto E, Romero R et al. Normal pregnancy is characterized by systemic activation of the complement system. J Matern Fetal Neonatal Med 2005 17 : 239 45.
14. Belmont HM, Hopkins P, Edelson HS et al. Complement activation during systemic lupus erythematosus. C3a and C5a anaphylatoxins circulate during exacerbations of disease. Arthritis Rheum 1986 29 : 1085 9.
15. Wild G, Watkins J, Ward AM, Hughes P, Hume A, Rowell NR. C4a anaphylatoxin levels as an indicator of disease activity in systemic lupus erythematosus. Clin Exp Immunol 1990 80 : 167 70.
16. Terui T, Takematsu H, Kato T, Ohkohchi K, Tagami H. Plasma anaphylatoxin concentrations in inflammatory skin diseases. Tohoku J Exp Med 1987 151 : 245 52.
17. Sorensen B, Streib JE, Strand M et al. Complement activation in a model of chronic fatigue syndrome. J Allergy Clin Immunol 2003 112 : 397 403.
18. Mocco J, Wilson DA, Komotar RJ et al. Alterations in plasma complement levels after human ischemic stroke. Neurosurgery 2006 59 : 28 33.
19. Mack WJ, Ducruet AF, Hickman ZL et al. Early plasma complement C3a levels correlate with functional outcome after aneurysmal subarachnoid hemorrhage. Neurosurgery 2007 61 : 255 60.
20. Cox BJ, Robins DM. Tissue-specific variation in C4 and Slp gene regulation. Nucleic Acids Res 1988 16 : 6857 70.
21. Kulics J, Circolo A, Strunk RC, Colten HR. Regulation of synthesis of complement protein C4 in human fibroblasts: cell- and gene-specific effects of cytokines and lipopolysaccharide. Immunology 1994 82 : 509 15.
22. Blanchin S, Estienne V, Durand-Gorde JM, Carayon P, Ruf J. Complement activation by direct C4 binding to thyroperoxidase in Hashimoto's thyroiditis. Endocrinology 2003 144 : 5422 9.
23. Tilton RC, Sand MN, Manak M. The Western immunoblot for Lyme disease: determination of sensitivity, specificity, and interpretive criteria with use of commercially available performance panels. Clin Infect Dis 1997 25 (Suppl 1 S31 4.
24. Binnicker MJ, Jespersen DJ, Harring JA, Rollins LO, Bryant SC, Beito EM. Evaluation of two commercial systems for the automated processing, reading and interpretation of Lyme Western blots. J Clin Microbiol 2008 46 : 2216 21.
25. Stricker RB, Johnson L. Searching for autoimmunity in "antibiotic-refractory" Lyme arthritis. Mol Immunol 2008 45 : 3023 4.
26. Kraiczy P, Hellwage J, Skerka C et al. Complement resistance of Borrelia burgdorferi correlates with the expression of BbCRASP-1, a novel linear plasmid-encoded surface protein that interacts with human factor H and FHL-1 and is unrelated to Erp proteins. J Biol Chem 2004 279 : 2421 9.
27. Ekdahl KN, Henningsson AJ, Sandholm K, Forsberg P, Ernerudh J, Ekerfelt C. Immunity in borreliosis with special emphasis on the role of complement. Adv Exp Med Biol 2007 598 : 198 213.
28. Schifferli JA, Steiger G, Paccaud JP. Complement mediated inhibition of immune precipitation and solubilization generate different concentrations of complement anaphylatoxins (C4a, C3a, C5a). Clin Exp Immunol 1986 64 : 407 14.
29. Mondino BJ, Sidikaro Y, Mayer FJ, Sumner HL. Inflammatory mediators in the vitreous humor of AIDS patients with retinitis. Invest Ophthalmol Vis Sci 1990 31 : 798 804.
30. Lian YC, Della-Negra M, Rutz R et al. Immunological analysis in paediatric HIV patients at different stages of the disease. Scand J Immunol 2004 60 : 615 24.